116 related articles for article (PubMed ID: 7407371)
1. [Effect of nonachlazine on ATP, ADP, and lactic acid concentration in intact and ischemic myocardium].
Turilova AI; Azvolinskaia TN; Kryzhanovskiĭ SA
Biull Eksp Biol Med; 1980 Jul; 89(7):49-51. PubMed ID: 7407371
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of nonachlazine and ethmozine on the cardiac blood supply in acute myocardial ischemia].
Pilipchuk DB
Farmakol Toksikol; 1981; 44(1):63-7. PubMed ID: 7021174
[TBL] [Abstract][Full Text] [Related]
3. [Possibility of the pharmacologic treatment of post-ischemic myocardial damage].
Rozonov IuB; Morozova TV; Markin VA; Pokazeeva ZT
Biull Eksp Biol Med; 1986 Sep; 102(9):301-3. PubMed ID: 3756329
[TBL] [Abstract][Full Text] [Related]
4. [Effect of nonachlazine on brain and myocardial noradrenaline content in normal rats and rats subjected to stress].
Turilova AI; Bendikov EA
Biull Eksp Biol Med; 1981 May; 91(5):580-2. PubMed ID: 7260390
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
Pilipchuk DB; Berger DIa; Sapozhkov AV
Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
[TBL] [Abstract][Full Text] [Related]
6. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
[TBL] [Abstract][Full Text] [Related]
7. [Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia].
Chichkanov GG; Bogolepov AK
Biull Eksp Biol Med; 1978 Dec; 86(12):691-4. PubMed ID: 728611
[TBL] [Abstract][Full Text] [Related]
8. [Action of nonachlazine on the creatine phosphokinase and acid phosphatase activity and on the lysosomal membrane stability of the ischemic myocardium in rats after preliminary reserpinization].
Sysoliatina NA
Farmakol Toksikol; 1986; 49(4):77-81. PubMed ID: 3758337
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of action of the antianginal drug nonachlazine on ischemic myocardium.
Kaverina NV; Turilova AI; Rozonov YuB ; Azvolinskaya TN; Kryzhanovsky SA
Adv Myocardiol; 1983; 4():575-87. PubMed ID: 6856982
[TBL] [Abstract][Full Text] [Related]
10. [Effect of short-term microcirculatory disorders on indices of myocardial energy metabolism].
Chernysheva GV; Vakar MD; Bogdanova EV; Amarantova GG
Biull Eksp Biol Med; 1977 Nov; 84(11):572-4. PubMed ID: 588733
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of the protective action of ethacizin on the ischemic myocardium].
Kaverina NV; Gatsura SV; Turilova AI
Biull Eksp Biol Med; 1984 Sep; 98(9):315-7. PubMed ID: 6386068
[TBL] [Abstract][Full Text] [Related]
12. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
Tereshchenko VP
Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
[No Abstract] [Full Text] [Related]
13. Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart.
Ichihara K; Abiko Y
J Pharmacol Exp Ther; 1982 Sep; 222(3):720-5. PubMed ID: 6286933
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of action of nonachlazine].
Oganesian NM; Oganesian SS; Varosian MA; Bagramian IG; Barinian SB
Farmakol Toksikol; 1981; 44(3):283-7. PubMed ID: 7286184
[TBL] [Abstract][Full Text] [Related]
15. [Effect of nonachlazine on ino- and chronotropic function].
Rozonov IuB; Chumburidze VB
Farmakol Toksikol; 1980; 43(5):575-9. PubMed ID: 7449987
[TBL] [Abstract][Full Text] [Related]
16. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
[No Abstract] [Full Text] [Related]
17. [Certain debatable questions concerning the use of nonachlazine in patients with chronic ischemic heart disease].
Iagus KhK
Ter Arkh; 1980; 52(9):97-101. PubMed ID: 7434242
[No Abstract] [Full Text] [Related]
18. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts.
Kobara M; Tatsumi T; Matoba S; Yamahara Y; Nakagawa C; Ohta B; Matsumoto T; Inoue D; Asayama J; Nakagawa M
J Mol Cell Cardiol; 1996 Feb; 28(2):417-28. PubMed ID: 8729072
[TBL] [Abstract][Full Text] [Related]
19. [Effect of nonachlazine on the energy provision for cardiac contractile activity in experimental myocardial infarct].
Reznikov KM; Provotorova PP; Sidel'nikova VI
Farmakol Toksikol; 1982; 45(5):52-7. PubMed ID: 7140956
[TBL] [Abstract][Full Text] [Related]
20. [Energy formation processes in the myocardium during measured limitation of coronary blood flow].
Frol'kis RA; Tsiomik VA; Likhtenshteĭn IE; Evstratova IN
Vopr Med Khim; 1981; 27(1):47-51. PubMed ID: 6258321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
